Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 for Arthritis Research: Study Type Comparison

Chemically Induced OA (Rat) Cartilage thickness, proteoglycan content 10–50 μg/kg daily 14–28 days Preserved cartilage thickness vs controls; reduced MMP-13 expression Strong evidence for chondroprotective effect in acute damage models Adjuvant-Induced RA (Rat

This comparison does not assign a generated winner or score.

  • Chemically Induced OA (Rat)
  • Cartilage thickness, proteoglycan content
  • 10–50 μg/kg daily
  • 14–28 days
  • Preserved cartilage thickness vs controls; reduced MMP-13 expression
  • Strong evidence for chondroprotective effect in acute damage models
  • Adjuvant-Induced RA (Rat)
  • Joint swelling, synovial inflammation
  • 10 μg/kg daily
  • 28 days
  • 42% reduction in paw swelling; decreased TNF-alpha and IL-1β in synovial fluid
  • Demonstrates anti-inflammatory mechanism distinct from NSAIDs
  • Surgical Meniscectomy (Rat)
  • Subchondral bone changes, osteophyte formation
  • 12 weeks
  • Reduced bone marrow lesions; slower osteophyte progression
  • Long-term study suggests disease-modifying potential, not just symptom control
  • Tendon-to-Bone Healing (Rat)
  • Collagen fiber alignment, biomechanical strength
  • 10–20 μg/kg daily
  • 21 days
  • 40% increase in collagen synthesis; improved tensile strength at 21 days
  • Mechanism applicable to ligament/tendon damage in arthritis
  • In Vitro Chondrocyte Culture
  • Gene expression (COL2A1, ACAN)
  • 1–10 μg/mL
  • 48–72 hours
  • Upregulated type II collagen and aggrecan expression
  • Direct cellular evidence of cartilage anabolic effect
More references

Related material